Local News: Chippewa Falls, WI 

 | 

Sign Up

 | 

Sign In

Advertisment

Merck News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Merck News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Merck News

News on Merck continually updated from thousands of sources around the net.

6 hrs ago | Myrtle Beach Online

The newest drugs may not always be the best

Last year pharmaceutical companies spent more than $4 billion urging patients like you to "ask your doctor" about their drugs.

Comment?

Related Topix: Drugs, Health, AARP, Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Cholesterol, Lipitor, Atorvastatin (generic), Medication

Sat Nov 07, 2009

Myrtle Beach Online

Pulte Homes, Merck, Garmin are big movers

The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange: NYSE: Pulte Homes Inc., up 32 cents at $9.55 Motorola, Alcoa, Procter & Gamble are big movers Motorola, Alcoa, Procter & Gamble are big movers The following stocks were among those that moved substantially or traded heavily ...

Comment?

Related Topix: Construction, Pulte, Biotech, Cable & Satellite, Garmin, Telecom, Medicine, Healthcare Industry, Financial Markets, Wireless, Motorola

Fri Nov 06, 2009

BusinessWeek

U.S. executive pensions r...

Pensions for top U.S. executive rose by an average of 19 percent last year, and more than 200 officers saw their retirement savings surge by as much as 50 percent, even as their companies stock prices fell, the Wall Street Journal reported on Monday.

Comment?

Related Topix: Pension, Personal Finance, Biotech, Medicine, Healthcare Industry

The Motley Fool

Slow Down There, Merck

Merck CEO Richard Clark says his company is looking to do more deals than ever, perhaps "even try to double" the current rate of 50 per year.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Johnson and Johnson, GlaxoSmithKline, SanofiSynthlabo

Thu Nov 05, 2009

MarketWatch

Biotech Stocks: Drug stocks gain; Alnylam slides

Drug stocks gained in early action Thursday, but shares of Alnylam Pharmaceuticals fell a day after it reported a widened third-quarter loss and said its search for research partners is taking longer than expected.

Comment?

Related Topix: Biotech, Science / Technology, Financial Markets, Alnylam Pharmaceuticals, 9, Cambridge, MA, Medicine, Healthcare Industry

Wed Nov 04, 2009

The Daily News

Merck, Now No. 2 Drugmaker, Set for Future Buys

The new Merck & Co . has become the world's second-biggest drugmaker overnight with a huge acquisition, but it still has a fat wallet and plans more wheeling and dealing.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Schering Plough, Pfizer, Whitehouse Station, NJ, Kenilworth, NJ, Opinion

MarketWatch

Market Snapshot: Wall Street upbeat ahead of Fed decision

U.S. stocks traded higher Wednesday ahead of an afternoon decision from the Federal Reserve, which is expected to keep its benchmark interest rate at a record low.

Comment?

Related Topix: Financial Markets, 9, Biotech, Medicine, Healthcare Industry, Media, Walt Disney, Television, Kraft Foods, Food

Bloomberg Business News

Breast Cancer Vaccine Tests German Merck's Strategy for $1 Billion Payoff

Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack cancer cells will increase its share of a $48 billion oncology market.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Health, Breast Cancer, Oncology, Lung Cancer

Tue Nov 03, 2009

HIV and Hepatitis

Longer STEP Follow-up Suggests Adenovirus HIV Vaccine Did Not...

SUMMARY: Over a longer follow-up period, the apparent link between adenovirus type 5 immunity and increased risk of HIV infection in the STEP vaccine trial diminished, researchers reported at the AIDS Vaccine 2009 conference last week in Paris.

Comment?

Related Topix: HIV/AIDS, Health, Biotech, Medicine, Healthcare Industry, San Francisco Metro

Mon Nov 02, 2009

Clover Herald

Schering-Plough reports data on hepatitis C drug

Schering-Plough Corp. said its experimental hepatitis C drug boceprevir helped eliminate the virus in about half of patients who did not respond to standard treatments.

Comment?

Related Topix: Schering Plough, Biotech, Medicine, Healthcare Industry, Hepatitis, Health, Kenilworth, NJ, Vertex Pharmaceuticals

WABC 7

FDA rejects Merck's drug application

U.S. regulators won't accept drugmaker Merck's application for a new combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Food and Drug Administration, Cholesterol, Health, Lipitor, Atorvastatin (generic), Medication

Earth Times

Nuevolution Announces Receipt of Milestone Payment From Merck & Co., Inc.

These include several accepted drug-like characteristics and nanomolar potency. In its collaboration with Merck, Nuevolution is applying its proprietary Chemetics technology to identify novel small molecule leads against drug targets of interest to Merck.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry

Sat Oct 31, 2009

Freshnews

'Project Runway' Designer Comes Full Circle to Educate About Living with HIV and Combat Stigma Associated with the Disease at United States Conference on AIDS

Jack Mackenroth, from the hit reality television series "Project Runway," is visiting San Francisco for the United States Conference on AIDS and is bringing Living Positive By Design , his national HIV and AIDS education initiative, to the city.

Comment?

Related Topix: HIV/AIDS, Health, Project Runway, Reality TV, Entertainment, Television, San Francisco Metro, Biotech, Medicine, Healthcare Industry, US Travel, Travel

Federal Trade Commission

FTC Order Restores Competition Lost Through Schering-Plougha s Acquisition of Merck

Merck & Co., Inc. must sell its interest in Merial Limited, an animal health joint venture with Sanofi-Aventis S.A., and Schering-Plough must sell its assets related to significant drugs for nausea and vomiting in humans, in order for Schering-Plough to complete its proposed $41.1 billion acquisition of Merck, the Federal Trade Commission announced ...

Comment?

Related Topix: Schering Plough, Biotech, Medicine, Healthcare Industry, SanofiSynthlabo

Fri Oct 30, 2009

Chicago Tribune

Freeport-McMoRan to replace Schering-Plough after merger with Merck, Priceline joins S&P 500

Standard & Poor's said Thursday it will add miner Freeport-McMoRan Copper & Gold Inc.

Comment?

Related Topix: Schering Plough, Biotech, Medicine, Healthcare Industry, Real Estate, Mining, FreeportMcMoRan Copper and Gold, Business News

Thu Oct 29, 2009

Market Wire

Competition Bureau Resolves Issues in Merger of Merck and Schering-Plough

The Competition Bureau announced today that it has reached an agreement with Merck & Co., Inc.

Comment?

Related Topix: Schering Plough, Biotech, Medicine, Healthcare Industry

Wed Oct 28, 2009

The Motley Fool

Swine Flu Doesn't Need to Save Novartis

Novartis has lots of moving parts, making it tricky to analyze, but it looks to me like the overall picture is pretty healthy.

Comment?

Related Topix: Biotech, Novartis, H1N1 Influenza / Swine Flu, Health, Pfizer, Medicine, Healthcare Industry, Influenza, Onyx Pharmaceuticals

Tue Oct 27, 2009

Myrtle Beach Online

Earnings Preview: Merck to report 3Q earnings

Merck & Co., a Dow component and the world's eighth-biggest drug maker by revenue, reports earnings for the third quarter on Thursday morning.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Asthma, Health, Singulair, Montelukast (generic), Medication, Schering Plough, 9, Bristol Myers Squibb

Mon Oct 26, 2009

Myrtle Beach Online

Merck says 3Q net income falls 28 percent

German drug and chemical maker Merck KGaA reported Monday that net income fell 28 percent to euro144 million in the third quarter as weak demand hurt revenue, but said its chemicals and liquid crystals divisions were recovering.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ, Rubber-Plastics, Manufacturing, Dow Chemical, Chemicals, Business News

SignOnSanDiego.com

Merck says 3Q net income falls 28 percent

In this Oct. 22, 2008 file photo, Merck & Co. headquarters in Whitehouse Station, N.J. is shown.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Whitehouse Station, NJ, TV, Electronics

Chippewa Falls Jobs

Also on Topix